ArticleBreast cancer : basic and clinical research2025
Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study.
Chung-Wu Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.